Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR4 | O00206 | 5/20 | 0.49 |
| ▸ | TLR2 | O60603 | 5/20 | 0.49 |
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.49 |
| ▸ | MAOA | P21397 | 3/20 | 0.49 |
| ▸ | MAOB | P27338 | 3/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | HTR2A | P28223 | 3/20 | 0.48 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.41 |
| ▸ | CDK1 | P06493 | 1/20 | 0.41 |
| ▸ | CDK4 | P11802 | 1/20 | 0.41 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.41 |
| ▸ | CCND1 | P24385 | 1/20 | 0.41 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.41 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30712080 | 0.84 | MAPT (0.46) | TLR4TLR2MAPTLMNASMN1; SMN2 | |
| SCHEMBL30712096 | 0.84 | MAPT (0.46) | TLR4TLR2MAPTLMNASMN1; SMN2 | |
| SCHEMBL14961123 | 0.82 | MAPT (0.45) | TLR4TLR2MAPTLMNASMN1; SMN2 | |
| SCHEMBL2890060 | 0.82 | PTGER4 (0.62) | LMNAHTR2APTGER1PTGER4PTGER3 | |
| SCHEMBL2890063 | 0.82 | PTGER4 (0.62) | LMNAHTR2APTGER1PTGER4PTGER3 | |
| SCHEMBL26690472 | 0.82 | MAPT (0.47) | TLR4TLR2MAPTLMNASMN1; SMN2 | |
| SCHEMBL26612430 | 0.82 | MAPT (0.47) | TLR4TLR2MAPTLMNASMN1; SMN2 | |
| SCHEMBL1728181 | 0.82 | HTR2A (0.53) | MAPTHTR2ACCNB2CDK1CDK4 | |
| SCHEMBL1728184 | 0.82 | HTR2A (0.53) | MAPTHTR2ACCNB2CDK1CDK4 | |
| SCHEMBL14907367 | 0.81 | TLR4 (0.50) | TLR4TLR2MAPTLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008797-A1 | PROCESSES OF PREPARING PSILOCIN AND PSILOCYBIN | TERRAN BIOSCIENCES INC (US) | 2026-01-08 | — | — | US | disclosed |
| US-20240317783-A1 | PROCESSES OF PREPARING PSILOCIN AND PSILOCYBIN | TERRAN BIOSCIENCES INC (US) | 2024-09-26 | — | — | US | disclosed |
| CN-116782896-A | Nitrifying galectin derivatives and their use for modulating 5-HT2A receptors and treating psychotic disorders | 恩维瑞克生物科学加拿大公司 | 2023-09-19 | — | — | CN | disclosed |
| EP-4208446-A1 | NITRATED PSILOCYBIN DERIVATIVES AND USE THEREOF FOR MODULATING 5-HT2A RECEPTOR AND FOR TREATING A PSYCHIATRIC DISORDER | Enveric Biosciences Canada Inc. (CA) | 2023-07-12 | — | — | EP | disclosed |
| WO-2022047583-A1 | NITRATED PSILOCYBIN DERIVATIVES AND USE THEREOF FOR MODULATING 5-HT2A RECEPTOR AND FOR TREATING A PSYCHIATRIC DISORDER | MAGICMED INDUSTRIES INC. (CA) | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240317783-A1 | PROCESSES OF PREPARING PSILOCIN AND PSILOCYBIN | PNMT, NISCH, HMBS | TLR4 4188/4885TLR2 4711/4885MAPT 1304/4885 |
| US-20260008797-A1 | PROCESSES OF PREPARING PSILOCIN AND PSILOCYBIN | DBH, HTR2C, HTR1B | TLR4 1450/4885TLR2 1085/4885MAPT 872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.